Categorical and correlational analyses of baseline fuorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI)

Banner Alzheimer's Institute and Banner Good Samaritan PET Center, Phoenix, AZ, USA.
NeuroImage (Impact Factor: 6.36). 06/2009; 45(4):1107-16. DOI: 10.1016/j.neuroimage.2008.12.072
Source: PubMed


In mostly small single-center studies, Alzheimer's disease (AD) is associated with characteristic and progressive reductions in fluorodeoxyglucose positron emission tomography (PET) measurements of the regional cerebral metabolic rate for glucose (CMRgl). The AD Neuroimaging Initiative (ADNI) is acquiring FDG PET, volumetric magnetic resonance imaging, and other biomarker measurements in a large longitudinal multi-center study of initially mildly affected probable AD (pAD) patients, amnestic mild cognitive impairment (aMCI) patients, who are at increased AD risk, and cognitively normal controls (NC), and we are responsible for analyzing the PET images using statistical parametric mapping (SPM). Here we compare baseline CMRgl measurements from 74 pAD patients and 142 aMCI patients to those from 82 NC, we correlate CMRgl with categorical and continuous measures of clinical disease severity, and we compare apolipoprotein E (APOE) varepsilon4 carriers to non-carriers in each of these subject groups. In comparison with NC, the pAD and aMCI groups each had significantly lower CMRgl bilaterally in posterior cingulate, precuneus, parietotemporal and frontal cortex. Similar reductions were observed when categories of disease severity or lower Mini-Mental State Exam (MMSE) scores were correlated with lower CMRgl. However, when analyses were restricted to the pAD patients, lower MMSE scores were significantly correlated with lower left frontal and temporal CMRgl. These findings from a large, multi-site study support previous single-site findings, supports the characteristic pattern of baseline CMRgl reductions in AD and aMCI patients, as well as preferential anterior CMRgl reductions after the onset of AD dementia.

Download full-text


Available from: Kewei Chen
  • Source
    • "One such extensively used neuroimaging technique is 18 F- Fluorodeoxyglucose positron emission tomography (FDG-PET) imaging, which can be used to evaluate the cerebral metabolic rate of glucose (CMRgl). Numerous FDG- PET studies (Nestor et al. 2003; Mosconi et al. 2005, 2008; Langbaum et al. 2009) have demonstrated significant reductions of CMRgl in brain regions in patients with AD and its prodromal stage mild cognitive impairment (MCI), compared with normal control (NC) subjects. These reduction could be used for the early detection of AD. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Traditional voxel-level multiple testing procedures in neuroimaging, mostly p-value based, often ignore the spatial correlations among neighboring voxels and thus suffer from substantial loss of power. We extend the local-significance-index based procedure originally developed for the hidden Markov chain models, which aims to minimize the false nondiscovery rate subject to a constraint on the false discovery rate, to three-dimensional neuroimaging data using a hidden Markov random field model. A generalized expectation-maximization algorithm for maximizing the penalized likelihood is proposed for estimating the model parameters. Extensive simulations show that the proposed approach is more powerful than conventional false discovery rate procedures. We apply the method to the comparison between mild cognitive impairment, a disease status with increased risk of developing Alzheimer's or another dementia, and normal controls in the FDG-PET imaging study of the Alzheimer's Disease Neuroimaging Initiative. © 2015, The International Biometric Society.
    Preview · Article · Apr 2014 · Biometrics
  • Source
    • "Neuropathological changes occur in the frontal cortex later in the course of AD (Braak and Braak, 1995; Petersen et al., 2006). Frontal lobe atrophy and hypometabolism is not present earlier than at the later stages of MCI and mainly in the prefrontal cortex (Fennema-Notestine et al., 2009; Langbaum et al., 2009; McDonald et al., 2009) but is more pronounced in those MCI patients who later converted to AD (Drzezga et al., 2003; Whitwell et al., 2008). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Although the memory impairment is a hallmark of Alzheimer's disease (AD), AD has also been characterized by spatial disorientation, which is present from its early stages. Spatial disorientation in AD manifests itself in getting lost in familiar and unfamiliar places and have been characterized more specifically using spatial navigation tests in both real space and virtual environments as an impairment in multiple spatial abilities, including allocentric and egocentric navigation strategies, visuo-spatial perception, or selection of relevant information for successful navigation. Patients suffering mild cognitive impairment (MCI), who are at a high risk of development of dementia, show impairment in a subset of these abilities, mainly connected with allocentric and egocentric processing. While spatial disorientation in typical AD patients probably reflects neurodegenerative changes in medial and posterior temporal, parietal, and frontal lobes, and retrosplenial cortex, the impairment of spatial navigation in MCI seem to be connected mainly with the medial temporal and also parietal brain changes. In this review, we will summarize the signs of brain disease in most MCI and AD patients showing in various tasks of spatial memory and navigation.
    Full-text · Article · Mar 2014 · Frontiers in Behavioral Neuroscience
  • Source
    • "However, conceptualizing the network in terms of suppression implies that the DMN is a sort of nuisance network where its importance to voluntary cognitive functions lies primarily in minimizing its activity during tasks. Consequently, patients with AD that demonstrate hypometabolism in the precuneus/posterior cingulate component of the DMN (Bradley et al., 2002; Chetelat et al., 2008; Langbaum et al., 2009; Petrie et al., 2009; Schroeter et al., 2009) should have very good cognitive functioning during purposeful tasks because the DMN is not active. However, this is clearly not the case. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The rapid demographical shift occurring in our society implies that understanding of healthy aging and age-related diseases is one of our major future challenges. Sensory impairments have an enormous impact on our lives and are closely linked to cognitive functioning. Due to the inherent complexity of sensory perceptions, we are commonly presented with a complex multisensory stimulation and the brain integrates the information from the individual sensory channels into a unique and holistic percept. The cerebral processes involved are essential for our perception of sensory stimuli and becomes especially important during the perception of emotional content. Despite ongoing deterioration of the individual sensory systems during aging, there is evidence for an increase in, or maintenance of, multisensory integration processing in aging individuals. Within this comprehensive literature review on multisensory integration we aim to highlight basic mechanisms and potential compensatory strategies the human brain utilizes to help maintain multisensory integration capabilities during healthy aging to facilitate a broader understanding of age-related pathological conditions. Further our goal was to identify where further research is needed.
    Full-text · Article · Dec 2013 · Frontiers in Human Neuroscience
Show more